| Summarized financial information |
|
|
|
|
|
|
|
|
|
Summary financial statements:
|
|
06/30/2020
|
|
06/30/2019
|
|
06/30/2018
|
|
Current assets
|
|
148,256,827
|
|
115,546,951
|
|
86,461,071
|
|
Non-current assets
|
|
49,843,457
|
|
47,418,450
|
|
48,295,110
|
|
Total assets
|
|
198,100,284
|
|
162,965,401
|
|
134,756,181
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
129,838,941
|
|
100,590,919
|
|
88,270,487
|
|
Non-current liabilities
|
|
32,935,399
|
|
34,788,705
|
|
29,598,319
|
|
Total liabilities
|
|
162,774,340
|
|
135,379,624
|
|
117,868,806
|
|
|
|
|
|
|
|
|
|
Equity attributable to controlling interest
|
|
35,324,227
|
|
27,584,666
|
|
16,824,251
|
|
Equity attributable to non-controlling interest
|
|
1,717
|
|
1,111
|
|
63,124
|
|
Total equity
|
|
35,325,944
|
|
27,585,777
|
|
16,887,375
|
|
|
|
|
|
|
|
|
|
Total liabilities and equity
|
|
198,100,284
|
|
162,965,401
|
|
134,756,181
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary statements of comprehensive income or loss
|
|
06/30/2020
|
|
06/30/2019
|
|
06/30/2018
|
|
Revenues
|
|
162,404,866
|
|
156,741,933
|
|
129,798,271
|
|
Initial recognition and changes in the fair value of biological assets
|
|
716,741
|
|
—
|
|
—
|
|
Cost of sales
|
|
(86,533,561)
|
|
(85,287,771)
|
|
(71,699,144)
|
|
Gross margin
|
|
76,588,046
|
|
71,454,162
|
|
58,099,127
|
|
|
|
|
|
|
|
|
|
Research and development expenses
|
|
(2,689,468)
|
|
(2,367,727)
|
|
(2,902,235)
|
|
Selling, general and administrative expenses
|
|
(36,103,289)
|
|
(31,316,843)
|
|
(31,219,784)
|
|
Share of profit or loss of joint ventures and associates
|
|
1,960,549
|
|
1,071,297
|
|
(1,683,949)
|
|
Other income
|
|
(380,871)
|
|
286,626
|
|
524,672
|
|
Operating profit
|
|
39,374,967
|
|
39,127,515
|
|
22,817,831
|
|
|
|
|
|
|
|
|
|
Financial results
|
|
(30,014,131)
|
|
(24,650,359)
|
|
(37,989,573)
|
|
Profit (loss) before taxes
|
|
9,360,836
|
|
14,477,156
|
|
(15,171,742)
|
|
|
|
|
|
|
|
|
|
Income tax (expense) benefit
|
|
(3,830,106)
|
|
(7,729,300)
|
|
3,275,077
|
|
Result for the year
|
|
5,530,730
|
|
6,747,856
|
|
(11,896,665)
|
|
|
|
|
|
|
|
|
|
Exchange differences on translation of foreign operations
|
|
1,281,974
|
|
17,197
|
|
(8,266,718)
|
|
Revaluation of property, plant and equipment, net of tax
|
|
3,921,091
|
|
(1,347,124)
|
|
14,079,875
|
|
Total comprehensive result
|
|
10,733,795
|
|
5,417,929
|
|
(6,083,508)
|
|